25 May 2013
Keywords: combination, studies, campto, crc, several, phase, i/ii
Article | 30 May 1997
Several Phase I/II studies of Rhone-Poulenc Rorer's Campto (irinotecan)in combination with 5-fluorouracil and folinic acid in patients with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.